NORTH BALDWIN INFIRMARY — History
CCN 010129 | 3-year financial timeline | COVID resilience: 100/100
🛡️ Public data only — no PHI permitted on this instance.
$55M
Latest Revenue (FY2022)
+27.7%
Revenue CAGR (3yr)
-3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $34M | $34M | $55M | +63.0% | +27.7% |
| Operating Expenses | $46M | $54M | $57M | +6.1% | +11.5% |
| Operating Margin | -35.4% | -58.6% | -3.3% | +94.4% | +0.0% |
| Net Income | $-12M | $-20M | $-2M | +91.0% | +0.0% |
| Licensed Beds | 25 | 25 | 35 | +40.0% | +18.3% |
| Total Patient Days | 6,001 | 6,255 | 5,282 | -15.6% | -6.2% |
| Medicare Day % | 24% | 21% | 25% | +20.3% | +1.2% |
| Medicaid Day % | 18% | 16% | 12% | -26.6% | -18.9% |
COVID Impact & Recovery
Resilience Score: 100/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +63.0% ($34M → $55M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+27.7%
This Hospital
+7.6%
State Avg
Latest Margin
-3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $66M | 12.8% |
| FY2024 (proj) | $77M | 28.9% |
| FY2025 (proj) | $87M | 44.9% |